Prime Medicine Appoints Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer
Go back to Prime Medicine Appoints Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer| (NASDAQ: PRME) | Delayed: 3.66 -0.01 (0.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.67 | 52 Week High | $21.72 | |||
| Open | $3.70 | 52 Week Low | $18.36 | |||
| Day High | $3.72 | P/E | N/A | |||
| Day Low | $3.49 | EPS | $0.00 | |||
| Volume | 1,578,523 | |||||
